Published Date: 26 Apr 2023
CAR T therapy is a lifesaver for 30 to 40% of lymphoma patients who receive it. CAR T therapy involves the removal of immune cells, and it is typically administered to lymphoma patients for whom other treatments have failed.
Read Full NewsEuthanasia should not be allowed for people seeking to be killed by medical professionals exclusively for mental illness reasons, according to a report published on...
An adenoviral-based immunotherapy improved disease-free survival in men with localized intermediate- or high-risk disease, but experts had reservations.
1.
Should the UK introduce targeted prostate cancer screening? The case for and against
2.
Survivors of childhood brain cancer are more likely to be held back in school
3.
RML to develop bone marrow transplantation at Lady Hardinge Medical College in Safdarjung
4.
Guidelines for patient training and radiation protection for patients treated with radioactive iodine for thyroid cancer
5.
BMTs that are "half-matched" are effective in treating severe sickle cell disease.
1.
Early Detection of Breast Cancer: Signs, Symptoms, and Screening Methods
2.
What Is Gastrinoma? Understanding This Rare Tumor and Its Treatment Options
3.
The Lowdown on Darbepoetin: Understanding Its Uses and Side Effects
4.
The Unfolding Revolution of Precision Medicine, Immunotherapy, and Digital Transformation in Medical Oncology 2025
5.
Cold Antibody AIHA and Neoplastic Disorders: Unraveling the Clinical and Pathogenic Link
1.
Asian Symposium on Advancement in Hematology and Oncology
2.
Asian Symposium on Advancement in Hematology and Oncology
3.
International Cancer Conference
4.
Asian Symposium on Advancement in Hematology and Oncology
5.
International Lung Cancer Congress®
1.
EGFR Mutation Positive Non-Small Cell Lung Cancer- Case Discussion & Conclusion
2.
Untangling The Best Treatment Approaches For ALK Positive Lung Cancer - Part V
3.
Current Scenario of Blood Cancer- A Conclusion on Genomic Testing & Advancement in Diagnosis and Treatment
4.
Key Takeaways from The CROWN Trial For ALK + NSCLC Patients with CNS Diseases
5.
Navigating the Complexities of Ph Negative ALL - Part IV
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation